NCT03935282Completed
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors (AH-HA)
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
The objective of this hybrid effectiveness-implementation study is to examine the effects of an EHR-based cardiovascular health assessment tool (AH-HA) among breast, prostate, colorectal, endometrial, and Hodgkin and non-Hodgkin lymphoma cancer survivors (N=600) receiving survivorship care in community oncology practices, using a group-randomized trial design (6 intervention practices and 6 usual care practices). Our central hypothesis is that the AH-HA tool will increase (1) cardiovascular health (CVH) discussions among survivors and oncology providers, (2) referrals and visits to primary care and cardiology (care coordination), and (3) cardiovascular (CV) risk reduction and health promotion activities compared to usual care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 645 (actual)
- First submitted
- 11 Apr 2019
- Start date
- 1 Oct 2020
- Primary completion date
- 7 Mar 2025
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Prostate cancer, Hodgkin lymphoma, Colorectal cancer
- NCT number
- NCT03935282
What you commit to
- Study type: Interventional
- Participants enrolled: 645
- From 1 Oct 2020 to the primary completion date, 7 Mar 2025
- 12 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Survivors who are currently on another interventional protocol in which cardiovascular risk factors (e.g., blood pressure, smoking, diet, physical activity) are being addressed, as per patient self-report or research staff members' knowledge at the time of consent.
Other illness
- Survivors will be excluded if they have a history of cancer recurrence for any cancer other than non-melanoma skin disease.
Other
- Prostate patients on active surveillance will be excluded.
- Survivor does not speak English or Spanish.
Who the study is looking for
- \>= 6 months post-potentially curative cancer treatment for breast, prostate, colorectal, or endometrial cancers or Hodgkin and non-Hodgkin lymphomas. Ongoing hormonal therapies such as tamoxifen, aromatase inhibitors (with or without adjuvant CDK 4/6 inhibitors such as abemaciclib), or androgen deprivation are allowed.
- Scheduled for a routine cancer-related follow-up care visit within the next 30 days with a provider who received training to use AH-HA.
- Able and willing to complete a follow-up assessment in one year.
- Survivors must have no evidence of disease at the time of last medical visit for all cancers, except non-melanoma skin disease.
- Age \>= 18 years.
- Able to understand and willing to provide verbal informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ThedaCare Regional Cancer Center Coordinator of this site? Confirm its status | Appleton | United States | Unknown status |
| Saint Louis Cancer and Breast Institute-Ballwin Coordinator of this site? Confirm its status | Ballwin | United States | Unknown status |
| Oncology Associates at Mercy Medical Center Coordinator of this site? Confirm its status | Cedar Rapids | United States | Unknown status |
| Mercy Hospital Fort Smith Coordinator of this site? Confirm its status | Fort Smith | United States | Unknown status |
| Baptist Memorial Hospital and Cancer Center-Memphis Coordinator of this site? Confirm its status | Memphis | United States | Unknown status |
| Baptist Memorial Hospital for Women Coordinator of this site? Confirm its status | Memphis | United States | Unknown status |
| Mercy Hospital Oklahoma City Coordinator of this site? Confirm its status | Oklahoma City | United States | Unknown status |
| Virginia Commonwealth University/Massey Cancer Center Coordinator of this site? Confirm its status | Richmond | United States | Unknown status |
| Community Medical Center Coordinator of this site? Confirm its status | Scranton | United States | Unknown status |
| Mercy Hospital Springfield Coordinator of this site? Confirm its status | Springfield | United States | Unknown status |
| Mercy Hospital Saint Louis Coordinator of this site? Confirm its status | St Louis | United States | Unknown status |
| Geisinger Wyoming Valley/Henry Cancer Center Coordinator of this site? Confirm its status | Wilkes-Barre | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.